TNXP
NASDAQ · Biotechnology
Tonix Pharmaceuticals Holdin
$9.74
-0.16 (-1.62%)
Open$10.01
Previous Close$9.90
Day High$10.09
Day Low$9.65
52W High$25.69
52W Low$9.40
Volume—
Avg Volume536.7K
Market Cap166.36M
P/E Ratio—
EPS$-12.92
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+318.3% upside
Current
$9.74
$9.74
Target
$40.74
$40.74
$28.14
$40.74 avg
$50.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.04M | 84.57M | 86.26M |
| Net Income | -246,357,043 | -20,699,385 | -25,319,011 |
| Profit Margin | -946.2% | -24.5% | -29.4% |
| EBITDA | -250,029,244 | -24,990,141 | -25,196,528 |
| Free Cash Flow | — | -20,292,095 | -20,848,476 |
| Rev Growth | — | +3.2% | +20.0% |
| Debt/Equity | — | 0.58 | 0.68 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $263.29 | -1.12% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $423.64 | +1.32% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $151.28 | -0.61% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $526.73 | -0.18% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $750.51 | -0.23% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $254.07 | -0.51% | 41.4 | 33.44B |